<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04890860</url>
  </required_header>
  <id_info>
    <org_study_id>2020/08</org_study_id>
    <nct_id>NCT04890860</nct_id>
  </id_info>
  <brief_title>Detection of Right Ventricular Dysfunction by Portal Vein Doppler After Cardiac Surgery</brief_title>
  <acronym>DVDDP</acronym>
  <official_title>Detection of Right Ventricular Dysfunction by Portal Vein Doppler After Cardiac Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CMC Ambroise Paré</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>CMC Ambroise Paré</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Right ventricular (RV) failure after cardiac surgery is associated with morbidity and&#xD;
      mortality, but is hard to diagnose with conventional echocardiographic means. RV dysfunction&#xD;
      may be associated with hepatic congestion, which may have an effect on portal veinous flow,&#xD;
      but this has not been extensively. The investigators aimed determine whether an increased&#xD;
      pulsatility in the portal venous flow was associated with RV dysfunction, after cardiac&#xD;
      surgery at risk of RV dysfunction: mitral and tricuspid valve procedures.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In cardiac surgical patients, RV dysfunction is associated with organ hypoperfusion and&#xD;
      venous congestion leading to increased morbidity and mortality.&#xD;
&#xD;
      Non-invasive methods used to assess RV function are 2D-echocardiographic measurement of&#xD;
      tricuspid annular plane systolic excursion (TAPSE), RV ejection fraction (EF), RV fractional&#xD;
      area change (FAC), 3D assessment of RV function, tissue Doppler assessment of velocities, and&#xD;
      magnetic resonance imaging (MRI). Though MRI is the gold standard method to assess RV&#xD;
      function, it cannot be used in the perioperative period.&#xD;
&#xD;
      In the present prospective observational study, The investigators investigated the&#xD;
      association between the pattern of portal venous flow and RV function as assessed by&#xD;
      echocardiography in the postoperative period.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 15, 2021</start_date>
  <completion_date type="Anticipated">June 15, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 15, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Right ventricular failure</measure>
    <time_frame>First 24 hours post cardiac surgery</time_frame>
    <description>systolic dysfunction (TAPSE below 16 mm or S wave below 9.5 cm/s)&#xD;
RV fractional area change below 35%&#xD;
End-diastole diameter ratio between RV and left ventricle &gt; 0.6&#xD;
Ratio between S and D wave or inverse D wave in supra-hepatic veins</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Portal flow measured by Doppler</measure>
    <time_frame>First 24 hours post cardiac surgery</time_frame>
    <description>flow pulsatility is assessed with the formula = 100 x (Vmax-Vmin)/Vmax. Time frame: First 24 hours post cardiac surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Echocardiographic acquisition</measure>
    <time_frame>First 24 hours post cardiac surgery</time_frame>
    <description>Feasability of all measurements (RV failure with the 4 criteria:&#xD;
systolic dysfunction (TAPSE below 16 mm or S wave below 9.5 cm/s)&#xD;
RV fractional area change below 35%&#xD;
End-diastole diameter ratio between RV and left ventricle &gt; 0.6&#xD;
Ratio between S and D wave or inverse D wave in supra-hepatic veins)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Echocardiographic acquisition</measure>
    <time_frame>First 24 hours post cardiac surgery</time_frame>
    <description>Feasability of all measurements (RV failure with the portal flow with Doppler)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Concordance of pulsatile flow assessment</measure>
    <time_frame>First 24 hours post cardiac surgery</time_frame>
    <description>Concordance of repeated measurements of the venous portal flow Time frame: First 24 hours post cardiac surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Concordance of RV dysfunction measurements</measure>
    <time_frame>First 24 hours post cardiac surgery</time_frame>
    <description>Concordance of repeated measurements of :&#xD;
systolic dysfunction (TAPSE below 16 mm or S wave below 9.5 cm/s)&#xD;
RV fractional area change below 35%&#xD;
End-diastole diameter ratio between RV and left ventricle &gt; 0.6&#xD;
Ratio between S and D wave or inverse D wave in supra-hepatic veins</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Preoperative RV dysfunction</measure>
    <time_frame>30 days before cardiac surgery</time_frame>
    <description>As defined&#xD;
systolic dysfunction (TAPSE below 16 mm or S wave below 9.5 cm/s)&#xD;
RV fractional area change below 35%&#xD;
End-diastole diameter ratio between RV and left ventricle &gt; 0.6&#xD;
Ratio between S and D wave or inverse D wave in supra-hepatic veins</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acute kidney injury</measure>
    <time_frame>one week after surgery</time_frame>
    <description>defined by KDIGO criteria as creatininemia elevation above &gt; 26 micromol/L during the first 48 hours or +50% during the first week, oliguria with urine output less than 0.5 mL/kg/h during 6 hours.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cholestasis</measure>
    <time_frame>one week after surgery</time_frame>
    <description>Conjugate bilirubin elevation above 12 mmol/L</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Postoperative Complications</condition>
  <condition>Heart Diseases</condition>
  <condition>Heart Failure</condition>
  <condition>Heart Valve Diseases</condition>
  <arm_group>
    <arm_group_label>Adults patients undergoing mitral and / or tricuspid valve surgery with cardiopulmonary bypass.</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>cardiac surgery involving mitral or tricuspid valve repair procedure, with cardiopulmonary bypass</intervention_name>
    <description>cardiac surgery involving mitral or tricuspid valve repair procedure, with cardiopulmonary bypass</description>
    <arm_group_label>Adults patients undergoing mitral and / or tricuspid valve surgery with cardiopulmonary bypass.</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  More than 18 years old&#xD;
&#xD;
          -  Ability to provide an informed consent&#xD;
&#xD;
          -  Planned mitral and / or tricuspid valve surgery under cardiopulmonary bypass.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Insufficient echogenicity&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CMC Ambroise Paré</name>
      <address>
        <city>Neuilly-sur-Seine</city>
        <zip>92200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>NGUYEN Lee, MD,PhD</last_name>
      <phone>+33 1 46 41 50 79</phone>
      <email>recherche@clinique-a-pare.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Haddad F, Couture P, Tousignant C, Denault AY. The right ventricle in cardiac surgery, a perioperative perspective: II. Pathophysiology, clinical importance, and management. Anesth Analg. 2009 Feb;108(2):422-33. doi: 10.1213/ane.0b013e31818d8b92. Review.</citation>
    <PMID>19151265</PMID>
  </reference>
  <reference>
    <citation>Haddad F, Couture P, Tousignant C, Denault AY. The right ventricle in cardiac surgery, a perioperative perspective: I. Anatomy, physiology, and assessment. Anesth Analg. 2009 Feb;108(2):407-21. doi: 10.1213/ane.0b013e31818f8623. Review.</citation>
    <PMID>19151264</PMID>
  </reference>
  <reference>
    <citation>Denault AY, Beaubien-Souligny W, Elmi-Sarabi M, Eljaiek R, El-Hamamsy I, Lamarche Y, Chronopoulos A, Lambert J, Bouchard J, Desjardins G. Clinical Significance of Portal Hypertension Diagnosed With Bedside Ultrasound After Cardiac Surgery. Anesth Analg. 2017 Apr;124(4):1109-1115. doi: 10.1213/ANE.0000000000001812.</citation>
    <PMID>28151822</PMID>
  </reference>
  <reference>
    <citation>Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, Solomon SD, Louie EK, Schiller NB. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2010 Jul;23(7):685-713; quiz 786-8. doi: 10.1016/j.echo.2010.05.010.</citation>
    <PMID>20620859</PMID>
  </reference>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>May 3, 2021</study_first_submitted>
  <study_first_submitted_qc>May 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 18, 2021</study_first_posted>
  <last_update_submitted>June 25, 2021</last_update_submitted>
  <last_update_submitted_qc>June 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cardiac surgery</keyword>
  <keyword>Echocardiography</keyword>
  <keyword>Right ventricular dysfunction</keyword>
  <keyword>Doppler</keyword>
  <keyword>Portal vein Doppler</keyword>
  <keyword>Ventricular function</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Ventricular Dysfunction</mesh_term>
    <mesh_term>Heart Valve Diseases</mesh_term>
    <mesh_term>Ventricular Dysfunction, Right</mesh_term>
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

